(S (NP-SBJ (NP (NN Expression)) (PP (IN of) (NP (NN Egr-1)))) (VP (VBZ correlates) (PP (IN with) (NP (NP-COOD (NP (DT the) (VBN transformed) (NN phenotype)) (CC and) (NP (NP (DT the) (NN type)) (PP (IN of) (NP (JJ viral) (NN latency))))) (PP (IN in) (NP (ADJP (NP (NN EBV) (NN genome)) (JJ positive)) (JJ lymphoid) (NN cell) (NNS lines)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (NP-SBJ-41 (PRP we)) (VP (VBP have) (VP (VBN investigated) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN Egr-1))) (PP (IN in) (NP (NN B) (NN cell) (NN growth) (NN regulation)))) (PP (IN by) (S (NP-SBJ (-NONE- *-41)) (VP (VBG examining) (NP (NP (DT the) (NN gene) (NN expression)) (PP (IN in) (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (NP (NN B) (NN cell) (NNS lines)) (, ,) (PP (VBG including) (NP (ADJP-COOD (CC both) (ADJP (NP (NN EBV) (NN genome)) (JJ negative)) (CC and) (ADJP (NN EBV) (VBG carrying))) (NN cell) (NNS lines))))))))))))) (. .))
(S (NP-SBJ (NN Egr-1) (NN expression)) (VP (VBZ correlates) (PP (IN with) (NP (NP-COOD (NP (DT the) (JJ cellular) (NN phenotype)) (CC and) (NP (NP (DT the) (JJ specific) (NN pattern)) (PP (IN of) (NP (JJ viral) (NN latency))))) (VP (VBN established) (NP (-NONE- *)) (PP (IN within) (NP (DT the) (JJ individual) (NN cell) (NNS lines))))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ-42 (NP (JJ constitutive) (NN activation)) (PP (IN of) (NP (NN Egr-1) (NN gene)))) (VP (VBZ is) (VP (ADVP (RB invariably)) (VBN associated) (NP (-NONE- *-42)) (PP (IN with) (NP (NP (JJ unrestricted) (NN expression)) (PP (IN of) (NP (JJ viral) (JJ latent) (NNS genes))) (PP (IN in) (NP (DT all) (NN group) (CD III) (ADJP (NP (NN EBV) (NN genome)) (VBG carrying)) (NN cell) (NNS lines))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-43 (NN Egr-1) (NN expression)) (VP (VBZ is) (VP (VBN abrogated) (NP (-NONE- *-43)) (PP (IN in) (NP (NN group) (NN I) (NN Burkitt) (NN tumor) (NNS cells))) (, ,) (ADVP (JJ irrespective) (PP (IN of) (NP (DT the) (NN EBV) (NN genome) (NN carrying) (NN status)))))) (. .))
(S (NP-SBJ (NP (VBN Activated) (JJ viral) (NN gene) (NN expression)) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (NP (JJ phenotypic) (NN conversion)) (PP (IN of) (NP (NN group) (NN I) (NN cell) (NNS lines))) (PP (IN in) (TO to) (NP (NN group) (NP-COOD (NP (CD II)) (CC or) (NP (CD III))))))))) (VP (VBZ restores) (NP (DT the) (NN Egr-1) (NN gene) (NN expression))) (. .))
(S-COOD (S (NP-SBJ-44 (NP (JJ Several) (NNS forms)) (PP (IN of) (NP (JJ EGR-1) (NN protein)))) (VP (VBP are) (VP (VBN found) (NP (-NONE- *-44)) (PP (IN within) (NP (NP (DT the) (JJ different) (NNS groups)) (PP (IN of) (NP (NN cell) (NNS lines)))))))) (, ,) (CC and) (S (NP-SBJ-45 (NP (DT the) (NN binding) (NN activity)) (PP (TO to) (NP (NN DNA) (NN consensus) (NNS sequences)))) (VP (VBD was) (VP (VBN investigated) (NP (-NONE- *-45))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP-SBJ (NP (NN time) (NN course) (NN analysis)) (PP (IN of) (NP (NP (NN Egr-1) (NN expression)) (PP-TMP (IN during) (NP (NP (DT the) (JJ early) (NNS steps)) (PP (IN of) (NP (NP (NN EBV) (NN infection)) (ADVP (FW in) (FW vitro))))))))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ-46 (NN Egr-1)) (VP (VBZ is) (VP (VBN upregulated) (NP (-NONE- *-46)) (PP-TMP (IN within) (NP (NP (NNS minutes)) (PP (IN from) (NP (NP (DT the) (JJ initial) (NN interaction)) (PP (IN with) (NP (DT the) (NN B) (NN lymphocyte)))))))))))) (. .))
